Moreover, there was a statistically significant correlation between uEVEpCAM-CD9 and Gleason grades in PCa patients (r = 0.215, 95% CI: 0.025–0.389, P = 0.023). The gene discussed is CD9; the disease is posterior cortical atrophy.